Clinical Trial Update: Efficacy and Safety of Tapentadol Extended Release Tablets in the Treatment of Moderate to Severe Pain in Subjects With Knee Osteoarthritis [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate the efficacy and safety of tapentadol extended-release tablets for moderate-to-severe pain in knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Nucynta ER (tapentadol extended-release)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Osteoarthitis, Chronic Pain | Phase 2 | Status: COMPLETED